Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult
Transplant Infectious Disease · 2023
DOI: 10.1111/tid.14022 ↗Kurz gefasst
Fallbericht in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Fabian Dammann und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Mpox, Monkeypox. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
We report a case of an immunocompromised man with monkeypox who experienced disease progression despite timely initiation of tecovirimat and ultimately required utilization of cidofovir and VIGIV for treatment. In immunocompromised patients, monkeypox might present with a more severe course of disease requiring consideration of alternative treatment strategies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Disease, Department of Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.
ORCID-Profile: Fabian Dammann, Jose F Camargo
Zitieren
APA
Dammann, F., Raja, M., & Camargo, J. F. (2023). Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Transplant Infectious Disease. https://doi.org/10.1111/tid.14022
Vancouver
Dammann F, Raja M, Camargo JF. Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult. Transplant Infectious Disease. 2023. doi:10.1111/tid.14022
BibTeX
@article{Dammann2023,
author = {Dammann, Fabian and Raja, Mohammed and Camargo, Jose F},
title = {Progression of human monkeypox infection despite tecovirimat in an immunocompromised adult},
journal = {Transplant Infectious Disease},
year = {2023},
doi = {10.1111/tid.14022}
}
EUVIMED